• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白 S 的层粘连蛋白 G1 残基介导其 TFPI 辅助因子功能,并受 C4BP 竞争性调节。

Laminin G1 residues of protein S mediate its TFPI cofactor function and are competitively regulated by C4BP.

机构信息

Centre for Haematology, Imperial College London, London, UK.

出版信息

Blood Adv. 2022 Jan 25;6(2):704-715. doi: 10.1182/bloodadvances.2021005382.

DOI:10.1182/bloodadvances.2021005382
PMID:34731882
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8791571/
Abstract

Protein S is a cofactor in the tissue factor pathway inhibitor (TFPI) anticoagulant pathway. It enhances TFPIα-mediated inhibition of factor (F)Xa activity and generation. The enhancement is dependent on a TFPIα-protein S interaction involving TFPIα Kunitz 3 and protein S laminin G-type (LG)-1. C4b binding protein (C4BP), which binds to protein S LG1, almost completely abolishes its TFPI cofactor function. However, neither the amino acids involved in TFPIα enhancement nor the mechanisms underlying the reduced TFPI cofactor function of C4BP-bound protein S are known. To screen for functionally important regions within protein S LG1, we generated 7 variants with inserted N-linked glycosylation attachment sites. Protein S D253T and Q427N/K429T displayed severely reduced TFPI cofactor function while showing normal activated protein C (APC) cofactor function and C4BP binding. Based on these results, we designed 4 protein S variants in which 4 to 6 surface-exposed charged residues were substituted for alanine. One variant, protein S K255A/E257A/D287A/R410A/K423A/E424A, exhibited either abolished or severely reduced TFPI cofactor function in plasma and FXa inhibition assays, both in the presence or absence of FV-short, but retained normal APC cofactor function and high-affinity C4BP binding. The C4BP β-chain was expressed to determine the mechanisms behind the reduced TFPI cofactor function of C4BP-bound protein S. Like C4BP-bound protein S, C4BP β-chain-bound protein S had severely reduced TFPI cofactor function. These results show that protein S Lys255, Glu257, Asp287, Arg410, Lys423, and Glu424 are critical for protein S-mediated enhancement of TFPIα and that binding of the C4BP β-chain blocks this function.

摘要

蛋白质 S 是组织因子途径抑制剂 (TFPI) 抗凝途径中的辅助因子。它增强了 TFPIα 介导的因子 (F)Xa 活性和生成的抑制作用。这种增强作用依赖于 TFPIα-蛋白质 S 相互作用,涉及 TFPIα Kunitz 3 和蛋白质 S 层粘连蛋白 G 型 (LG)-1。C4b 结合蛋白 (C4BP) 结合蛋白质 S LG1,几乎完全消除其 TFPI 辅助因子功能。然而,与 TFPIα 增强相关的氨基酸以及 C4BP 结合的蛋白质 S 的 TFPI 辅助因子功能降低的机制尚不清楚。为了筛选蛋白质 S LG1 内具有功能重要性的区域,我们生成了 7 种带有插入的 N-连接糖基化附着位点的变体。蛋白质 S D253T 和 Q427N/K429T 显示出严重降低的 TFPI 辅助因子功能,同时表现出正常的激活蛋白 C (APC) 辅助因子功能和 C4BP 结合。基于这些结果,我们设计了 4 种蛋白质 S 变体,其中 4 到 6 个表面暴露的带电残基被替换为丙氨酸。一种变体,蛋白质 S K255A/E257A/D287A/R410A/K423A/E424A,在存在或不存在 FV-短的情况下,在血浆和 FXa 抑制测定中表现出要么完全消除要么严重降低的 TFPI 辅助因子功能,但保留正常的 APC 辅助因子功能和高亲和力 C4BP 结合。表达 C4BPβ 链以确定 C4BP 结合的蛋白质 S 的 TFPI 辅助因子功能降低的机制。与 C4BP 结合的蛋白质 S 一样,C4BPβ 链结合的蛋白质 S 具有严重降低的 TFPI 辅助因子功能。这些结果表明,蛋白质 S 的赖氨酸 255、谷氨酸 257、天冬氨酸 287、精氨酸 410、赖氨酸 423 和谷氨酸 424 对于蛋白质 S 介导的 TFPIα 增强是至关重要的,并且 C4BPβ 链的结合阻断了这种功能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c992/8791571/31517fa01605/advancesADV2021005382f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c992/8791571/7b928ba13377/advancesADV2021005382absf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c992/8791571/4b5b96531abb/advancesADV2021005382f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c992/8791571/e0fdeb110f18/advancesADV2021005382f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c992/8791571/77ff6f0f14d6/advancesADV2021005382f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c992/8791571/9820c791dc58/advancesADV2021005382f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c992/8791571/ae399e6d3d96/advancesADV2021005382f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c992/8791571/31517fa01605/advancesADV2021005382f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c992/8791571/7b928ba13377/advancesADV2021005382absf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c992/8791571/4b5b96531abb/advancesADV2021005382f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c992/8791571/e0fdeb110f18/advancesADV2021005382f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c992/8791571/77ff6f0f14d6/advancesADV2021005382f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c992/8791571/9820c791dc58/advancesADV2021005382f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c992/8791571/ae399e6d3d96/advancesADV2021005382f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c992/8791571/31517fa01605/advancesADV2021005382f6.jpg

相似文献

1
Laminin G1 residues of protein S mediate its TFPI cofactor function and are competitively regulated by C4BP.蛋白 S 的层粘连蛋白 G1 残基介导其 TFPI 辅助因子功能,并受 C4BP 竞争性调节。
Blood Adv. 2022 Jan 25;6(2):704-715. doi: 10.1182/bloodadvances.2021005382.
2
Amino acid residues in the laminin G domains of protein S involved in tissue factor pathway inhibitor interaction.参与组织因子途径抑制物相互作用的蛋白S层粘连蛋白G结构域中的氨基酸残基。
Thromb Haemost. 2015 May;113(5):976-87. doi: 10.1160/TH14-09-0803. Epub 2015 Feb 26.
3
Novel insights into the regulation of coagulation by factor V isoforms, tissue factor pathway inhibitorα, and protein S.新型因子 V 异构体、组织因子途径抑制物α 和蛋白 S 对凝血的调控作用的新见解。
J Thromb Haemost. 2017 Jul;15(7):1241-1250. doi: 10.1111/jth.13665.
4
TFPI cofactor function of protein S: essential role of the protein S SHBG-like domain.蛋白S的组织因子途径抑制物(TFPI)辅因子功能:蛋白S性激素结合球蛋白样结构域的关键作用。
Blood. 2014 Jun 19;123(25):3979-87. doi: 10.1182/blood-2014-01-551812. Epub 2014 Apr 16.
5
Importance of individual residues in hydrophobic patch PLVIVGL (1481-1487) in FV-Short for synergistic TFPIα cofactor activity with protein S, an alanine-scanning study: AlphaFold-mediated prediction of FV-Short/TFPIα/protein S trimolecular complex structure.FV-Short中疏水区PLVIVGL(1481 - 1487)中单个残基对于与蛋白S协同发挥组织因子途径抑制物α(TFPIα)辅因子活性的重要性:一项丙氨酸扫描研究:基于AlphaFold介导的FV-Short/TFPIα/蛋白S三分子复合物结构预测
J Thromb Haemost. 2025 Mar;23(3):849-862. doi: 10.1016/j.jtha.2024.11.013. Epub 2024 Nov 29.
6
The preAR2 region (1458-1492) in factor V-Short is crucial for the synergistic TFPIα-cofactor activity with protein S and the assembly of a trimolecular factor Xa-inhibitory complex comprising FV-Short, protein S, and TFPIα.因子 V-Short 中的 preAR2 区域(1458-1492)对于与蛋白 S 的协同 TFPIα 辅因子活性以及包含 FV-Short、蛋白 S 和 TFPIα 的三分子因子 Xa 抑制性复合物的组装至关重要。
J Thromb Haemost. 2022 Jan;20(1):58-68. doi: 10.1111/jth.15547. Epub 2021 Oct 19.
7
Factor V has an anticoagulant cofactor activity that targets the early phase of coagulation.因子V具有针对凝血早期阶段的抗凝辅因子活性。
J Biol Chem. 2017 Jun 2;292(22):9335-9344. doi: 10.1074/jbc.M116.769570. Epub 2017 Apr 18.
8
A hydrophobic patch (PLVIVG; 1481-1486) in the B-domain of factor V-short is crucial for its synergistic TFPIα-cofactor activity with protein S and for the formation of the FXa-inhibitory complex comprising FV-short, TFPIα, and protein S.FV 短链 B 结构域中的疏水性补丁(PLVIVG;1481-1486)对于其与蛋白 S 的协同 TFPIα 辅因子活性以及 FXa 抑制性复合物的形成至关重要,该复合物包含 FV 短链、TFPIα 和蛋白 S。
J Thromb Haemost. 2022 May;20(5):1146-1157. doi: 10.1111/jth.15690. Epub 2022 Mar 16.
9
New functional test for the TFPIα cofactor activity of Protein S working in synergy with FV-Short.新型功能性试验检测 Protein S 与 FV-Short 协同作用下对 TFPIα 辅因子活性的影响
J Thromb Haemost. 2019 Apr;17(4):585-595. doi: 10.1111/jth.14405. Epub 2019 Mar 11.
10
Protein S is a cofactor for platelet and endothelial tissue factor pathway inhibitor-α but not for cell surface-associated tissue factor pathway inhibitor.蛋白 S 是血小板和血管内皮组织因子途径抑制剂-α的辅助因子,但不是细胞表面相关组织因子途径抑制剂的辅助因子。
Arterioscler Thromb Vasc Biol. 2014 Jan;34(1):169-76. doi: 10.1161/ATVBAHA.113.302655. Epub 2013 Nov 14.

引用本文的文献

1
The common VTE-protective G haplotype of F5 increases factor V-short, TFPI function, and risk of bleeding.凝血因子V常见的VTE保护性G单倍型增加了凝血因子V短链、组织因子途径抑制物(TFPI)的功能以及出血风险。
Blood Adv. 2025 Jan 14;9(1):132-142. doi: 10.1182/bloodadvances.2024014020.
2
Tissue factor pathway inhibitor - cofactor-dependent regulation of the initiation of coagulation.组织因子途径抑制剂 - 辅因子依赖性调节凝血的启动。
Curr Opin Hematol. 2024 Nov 1;31(6):315-320. doi: 10.1097/MOH.0000000000000838. Epub 2024 Aug 26.
3
Factor V variants in bleeding and thrombosis.

本文引用的文献

1
Regulation of factor V and factor V-short by TFPIα: Relationship between B-domain proteolysis and binding.TFPIα 对因子 V 和因子 V 短片段的调节:B 结构域蛋白水解与结合的关系。
J Biol Chem. 2021 Jan-Jun;296:100234. doi: 10.1074/jbc.RA120.016341. Epub 2021 Jan 7.
2
Anticoagulant protein S-New insights on interactions and functions.抗凝血蛋白S——关于相互作用和功能的新见解
J Thromb Haemost. 2020 Nov;18(11):2801-2811. doi: 10.1111/jth.15025. Epub 2020 Aug 24.
3
Platelet protein S limits venous but not arterial thrombosis propensity by controlling coagulation in the thrombus.
出血和血栓形成中的凝血因子V变体
Res Pract Thromb Haemost. 2024 Jan 26;8(1):102330. doi: 10.1016/j.rpth.2024.102330. eCollection 2024 Jan.
4
TFPIα anticoagulant function is highly dependent on protein S in vivo.TFPIα 的抗凝功能在体内高度依赖于蛋白质 S。
Sci Adv. 2024 Feb 2;10(5):eadk5836. doi: 10.1126/sciadv.adk5836.
5
Illustrated State-of-the-Art Capsules of the ISTH 2022 Congress.国际血栓与止血学会(ISTH)2022年大会的图说前沿胶囊。
Res Pract Thromb Haemost. 2022 Jul 6;6(5):e12747. doi: 10.1002/rth2.12747. eCollection 2022 Jul.
6
The first laminin G-like domain of protein S is essential for binding and activation of Tyro3 receptor and intracellular signalling.蛋白S的首个层粘连蛋白G样结构域对于酪氨酸激酶3(Tyro3)受体的结合与激活以及细胞内信号传导至关重要。
Biochem Biophys Rep. 2022 Apr 28;30:101263. doi: 10.1016/j.bbrep.2022.101263. eCollection 2022 Jul.
7
A hydrophobic patch (PLVIVG; 1481-1486) in the B-domain of factor V-short is crucial for its synergistic TFPIα-cofactor activity with protein S and for the formation of the FXa-inhibitory complex comprising FV-short, TFPIα, and protein S.FV 短链 B 结构域中的疏水性补丁(PLVIVG;1481-1486)对于其与蛋白 S 的协同 TFPIα 辅因子活性以及 FXa 抑制性复合物的形成至关重要,该复合物包含 FV 短链、TFPIα 和蛋白 S。
J Thromb Haemost. 2022 May;20(5):1146-1157. doi: 10.1111/jth.15690. Epub 2022 Mar 16.
血小板蛋白 S 通过控制血栓中的凝血来限制静脉血栓形成倾向,但不限制动脉血栓形成倾向。
Blood. 2020 May 28;135(22):1969-1982. doi: 10.1182/blood.2019003630.
4
New functional test for the TFPIα cofactor activity of Protein S working in synergy with FV-Short.新型功能性试验检测 Protein S 与 FV-Short 协同作用下对 TFPIα 辅因子活性的影响
J Thromb Haemost. 2019 Apr;17(4):585-595. doi: 10.1111/jth.14405. Epub 2019 Mar 11.
5
Factor V-short and protein S as synergistic tissue factor pathway inhibitor (TFPIα) cofactors.因子V短型和蛋白S作为协同组织因子途径抑制剂(TFPIα)辅因子。
Res Pract Thromb Haemost. 2017 Dec 20;2(1):114-124. doi: 10.1002/rth2.12057. eCollection 2018 Jan.
6
Factor V Has Anticoagulant Activity in Plasma in the Presence of TFPIα: Difference between FV1 and FV2.在 TFPIα 的存在下,因子 V 在血浆中具有抗凝活性:FV1 和 FV2 之间的差异。
Thromb Haemost. 2018 Jul;118(7):1194-1202. doi: 10.1055/s-0038-1656549. Epub 2018 Jun 4.
7
Correlates of plasma and platelet tissue factor pathway inhibitor, factor V, and Protein S.血浆及血小板组织因子途径抑制物、因子V和蛋白S的相关因素
Res Pract Thromb Haemost. 2018 Jan;2(1):93-104. doi: 10.1002/rth2.12058. Epub 2017 Dec 29.
8
Factor V has an anticoagulant cofactor activity that targets the early phase of coagulation.因子V具有针对凝血早期阶段的抗凝辅因子活性。
J Biol Chem. 2017 Jun 2;292(22):9335-9344. doi: 10.1074/jbc.M116.769570. Epub 2017 Apr 18.
9
Tissue Factor Pathway Inhibitor: Multiple Anticoagulant Activities for a Single Protein.组织因子途径抑制剂:单一蛋白质的多种抗凝活性。
Arterioscler Thromb Vasc Biol. 2016 Jan;36(1):9-14. doi: 10.1161/ATVBAHA.115.305996. Epub 2015 Nov 24.
10
Amino acid residues in the laminin G domains of protein S involved in tissue factor pathway inhibitor interaction.参与组织因子途径抑制物相互作用的蛋白S层粘连蛋白G结构域中的氨基酸残基。
Thromb Haemost. 2015 May;113(5):976-87. doi: 10.1160/TH14-09-0803. Epub 2015 Feb 26.